Merck & Co., Inc., known as MRK in the stock exchange, is a globally recognized pharmaceutical organization that is dedicated to addressing some of the biggest health challenges around the world. Founded in 1891 as a subsidiary of the German company Merck, which was established in 1668, Merck & Co. has since become a separate and independently operated company since WW1. Headquartered in Kenilworth, New Jersey, USA, this multinational organization is on the frontline in the development, manufacturing, and delivery of innovative health solutions that improve health outcomes for people worldwide.
Over the years, Merck & Co. has evolved into one of the largest pharmaceutical companies operating across four primary divisions: Pharmaceuticals, Animal Health, Healthcare Services, and Alliances. With a robust portfolio of medicine therapies, vaccines, biologic therapies, animal health, and consumer care products, the company holds a leading position in several therapeutic areas, including oncology, cardiovascular diseases, diabetes, and infectious diseases.
Following a research-driven approach, Merck & Co invests heavily in Research & Development (R&D), aiming to discover and develop innovative health solutions. Its R&D strategy focuses on harnessing breakthrough science in areas that will considerably impact health and well-being, thus improving human and animal health worldwide.
Notably, Merck & Co. made significant contributions towards the development of therapies for HIV and AIDS, and more recently, it played a significant role in the battle against the global pandemic, contributing to the manufacturing of the Johnson & Johnson COVID-19 vaccine.
On the corporate social responsibility front, Merck & Co. is committed to improving access to healthcare. Its Merck for Mothers program, launched in 2011, has significantly reduced maternal mortality rates in several parts of the globe by ensuring safe pregnancy and childbirth.
Its position on sustainability is clear and it is committed to making a positive impact on global health and the environment while ensuring its business sustainability. It focuses on areas such as product responsibility, environmental sustainability, employee health and safety, and ethical sourcing and human rights.
Through unmatched innovation, strategic collaborations, and a commitment to sustainably improving global health, Merck & Co., Inc. continues to play a vital role in the global pharmaceutical sector. As of 2022, the company remains an essential player in addressing public health challenges and develops therapies that address previously unmet medical needs, thereby driving the advancement of healthcare and enriching lives worldwide.